BioVaxys Technology Corp. (CSE:BIOV)
 0.2750
 +0.0400 (17.02%)
  Oct 30, 2025, 3:53 PM EDT
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of CAD 8.07 million as of October 31, 2025. Its market cap has decreased by -50.94% in one year.
Market Cap 
 8.07M
Enterprise Value 
 8.20M
Revenue 
 n/a
Ranking 
 n/a
PE Ratio 
 n/a
Stock Price 
0.28
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 8.07M, a decrease of -70.18%. That is a compound annual growth rate of -21.24%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 8.07M | -51.03% | 
| Dec 31, 2024 | 16.48M | 127.10% | 
| Dec 29, 2023 | 7.26M | -47.89% | 
| Dec 30, 2022 | 13.92M | -26.37% | 
| Dec 31, 2021 | 18.91M | 32.10% | 
| Dec 31, 2020 | 14.32M | -47.09% | 
| Oct 6, 2020 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Curaleaf Holdings | 3.09B | 
| Green Thumb Industries | 2.30B | 
| dentalcorp Holdings | 2.18B | 
| Trulieve Cannabis | 1.89B | 
| Sienna Senior Living | 1.81B | 
| Extendicare | 1.34B | 
| Cronos Group | 1.33B | 
| WELL Health Technologies | 1.32B |